Revvity Inc. (NYSE:RVTY) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Revvity Inc. (NYSE:RVTY - Get Free Report) has received an average rating of "Moderate Buy" from the fifteen analysts that are currently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $125.64.

Several equities analysts have recently commented on RVTY shares. Wall Street Zen lowered shares of Revvity from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Wells Fargo & Company cut their target price on Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 17th. JPMorgan Chase & Co. lowered their price target on Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research report on Tuesday, April 29th. Barclays dropped their price objective on Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. Finally, The Goldman Sachs Group decreased their target price on Revvity from $140.00 to $125.00 and set a "buy" rating on the stock in a research note on Tuesday, April 29th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Nomura Holdings Inc. purchased a new stake in shares of Revvity during the 4th quarter worth $447,000. Victory Capital Management Inc. raised its stake in Revvity by 17.4% in the fourth quarter. Victory Capital Management Inc. now owns 70,250 shares of the company's stock valued at $7,841,000 after buying an additional 10,390 shares in the last quarter. Private Advisor Group LLC lifted its holdings in Revvity by 5.3% during the 4th quarter. Private Advisor Group LLC now owns 4,254 shares of the company's stock worth $475,000 after buying an additional 213 shares during the last quarter. Jones Financial Companies Lllp boosted its position in shares of Revvity by 39.8% during the 4th quarter. Jones Financial Companies Lllp now owns 4,312 shares of the company's stock worth $481,000 after acquiring an additional 1,228 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new position in shares of Revvity in the 4th quarter valued at about $2,248,000. Institutional investors and hedge funds own 86.65% of the company's stock.

Revvity Trading Down 2.2%

NYSE:RVTY traded down $2.13 on Friday, reaching $94.22. The company's stock had a trading volume of 1,157,274 shares, compared to its average volume of 958,240. Revvity has a 12-month low of $87.70 and a 12-month high of $129.50. The stock has a 50 day moving average price of $93.15 and a 200 day moving average price of $106.51. The firm has a market cap of $11.11 billion, a price-to-earnings ratio of 40.09, a price-to-earnings-growth ratio of 2.35 and a beta of 0.97. The company has a quick ratio of 2.99, a current ratio of 3.58 and a debt-to-equity ratio of 0.41.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.05. The firm had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. Revvity had a net margin of 10.35% and a return on equity of 7.73%. Revvity's revenue was up 2.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.98 EPS. On average, equities analysts anticipate that Revvity will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 annualized dividend and a yield of 0.30%. Revvity's dividend payout ratio (DPR) is 11.91%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.